» Articles » PMID: 19383732

Prevalence, Incidence, and Prognostic Value of Anaemia in Patients After an Acute Myocardial Infarction: Data from the OPTIMAAL Trial

Overview
Journal Eur Heart J
Date 2009 Apr 23
PMID 19383732
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The prevalence, incidence, and prognostic value of anaemia in patients with an acute myocardial infarction (AMI) complicated by heart failure is unclear.

Methods And Results: We analysed the relationship between haemoglobin (Hb) and outcome in 5010 patients with AMI complicated by heart failure in the OPTIMAAL study. In 3921 patients, follow-up Hb levels were available at 365 (+/-90) days. In a subgroup of 224 patients, iron-related haematinics were assessed at baseline and during follow-up. At baseline, mean Hb was 12.6 +/- 1.3 g/dL in women and 13.7 +/- 1.4 g/dL in men. Hb < 11.5 g/dL was found in 9.3% of patients (women: 18.2%, men: 5.8%). Lower haemoglobin at baseline was clearly associated with female gender and the presence of diabetes, higher age and Killip class, lower body mass index, systolic blood pressure, total cholesterol, and the absence of current smoking (all P < 0.05). Higher Hb [per one standard deviation (SD)] related to lower mortality [adjusted hazard ratios (HR) 0.88; 95% confidence interval (CI) 0.83-0.93], CHF hospitalizations [HR 0.85 (0.77-0.93)], and all-cause hospitalizations [HR 0.96 (0.92-0.99), all P < 0.05]. In patients without anaemia at baseline, the anaemia incidence after 1 year of follow-up was 10.1% in women and 10.0% in men. Of patients with anaemia at baseline, 65% did not have anaemia at 12 months and 46% did not have anaemia at any time during follow-up (median 3.0 years, inter-quartile range, Q1-Q3 = 2.7-3.3 years). At 12 months, an increase in Hb (per SD) was related to lower mortality [HR 0.73 (0.63-0.85; P < 0.0001)] independent of baseline Hb and other clinical characteristics.

Conclusion: In patients with complicated AMIs, anaemia on admission and/or reductions in haemoglobin during follow-up are independent risk factors for mortality and hospitalization. Studies are warranted to determine whether correcting anaemia after a complicated AMI improves outcome.

Citing Articles

Effect of Peri-Interventional Blood Loss on In-Stent Thrombosis After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction.

Youssef A, Mashaly A, Alkomi U, Christoph M, Abdelsamad A, Quick S J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997501 PMC: 11856059. DOI: 10.3390/jcdd12020067.


Impact of anemia on clinical outcomes in patients with multivessel coronary artery disease treated with percutaneous coronary intervention.

Jonik S, Skrobucha A, Huczek Z, Kochman J, Opolski G, Grabowski M Postepy Kardiol Interwencyjnej. 2025; 20(4):393-400.

PMID: 39897000 PMC: 11783259. DOI: 10.5114/aic.2024.144778.


Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial.

Carrier F, Cooper H, Portela G, Bertolet M, Lemesle G, Prochaska M JAMA Netw Open. 2024; 7(11):e2442361.

PMID: 39485351 PMC: 11530937. DOI: 10.1001/jamanetworkopen.2024.42361.


Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study.

Falah B, Redfors B, Zhao D, Bharadwaj A, Basir M, Thompson J Front Cardiovasc Med. 2024; 11:1429900.

PMID: 39091353 PMC: 11291217. DOI: 10.3389/fcvm.2024.1429900.


Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients.

Choudhary R, Khan M, Dosi R, Choudhari S, Pawar D, Shahavi V Indian Heart J. 2024; 76(4):280-285.

PMID: 39009075 PMC: 11451355. DOI: 10.1016/j.ihj.2024.07.007.